M Sea Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.97 Cr
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.67 Cr
- Revenue Growth 27.02%
- Profit Growth 14.66%
- Ebitda 15.50%
- Net Worth 1.75%
- Total Assets 17.68%
About M Sea Pharmaceuticals
M Sea Pharmaceuticals Private Limited (MSPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 April 2015 (Nine years and ten months 4 days old ). Its registered office is in Sirmaur, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.97 Cr.
The company currently has active open charges totaling ₹12.67 Cr.
Ajay Agarwal, Krishnamoorthy Chandru, Selvaraj Kumar, and Three other members serve as directors at the Company.
Company Details
-
Location
Sirmaur, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900HP2015PTC000911
-
Company No.
000911
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Apr 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at M Sea Pharmaceuticals?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Agarwal
|
Director | 22-Feb-2018 | Current |
|
Krishnamoorthy Chandru
|
Director | 01-Apr-2015 | Current |
|
Selvaraj Kumar
|
Director | 19-Nov-2015 | Current |
|
Harinath Harinath
|
Director | 19-Nov-2015 | Current |
|
Shailender Kumar
|
Director | 31-Mar-2017 | Current |
|
Manish Agarwal
|
Director | 13-Nov-2018 | Current |
Financial Performance of M Sea Pharmaceuticals.
M Sea Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.02% increase. The company also saw a substantial improvement in profitability, with a 14.66% increase in profit. The company's net worth moved up by a moderate rise of 1.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M Sea Pharmaceuticals?
In 2022, M Sea Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Reddy Life Sciences Private LimitedKrishnamoorthy Chandru is a mutual person
-
Altar Pharmaceuticals Private LimitedAjay Agarwal is a mutual person
-
Daksh Pharmaceuticals Private LimitedAjay Agarwal is a mutual person
-
New Medicon Pharma Lab Private LimitedSelvaraj Kumar and Harinath Harinath are mutual person
-
Enerbay Lifesciences Private LimitedKrishnamoorthy Chandru is a mutual person
-
Reo Remedies Private Limited
Krishnamoorthy Chandru is a mutual person
Charges (Loans)
₹12.67 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 7.82 Cr
- Others : 4.86 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 May 2021 | Hdfc Bank Limited | ₹7.82 Cr | Open |
| 31 Aug 2018 | Others | ₹2.51 Cr | Open |
| 30 Jan 2016 | Others | ₹2.35 Cr | Open |
How Many Employees Work at M Sea Pharmaceuticals?
Unlock and access historical data on people associated with M Sea Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M Sea Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M Sea Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
